How routine use of a treat to target approach in PsA might impact on clinical decision making

Παρόμοια τεκμήρια

• Treat-to-target in PsA: methods and necessity
  ανά: Dures, E, κ.ά.
  Έκδοση: (2020)
• What should be the primary target of ‘treat to target’ in PsA?
  ανά: Coates, L, κ.ά.
  Έκδοση: (2018)
• Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
  ανά: McGagh, D, κ.ά.
  Έκδοση: (2020)
• Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
  ανά: Coates, LC, κ.ά.
  Έκδοση: (2021)
• Treat to target in PsA should focus on clinical measures. Response to: ‘DAPSA versus cDAPSA: do we need use CRP?’ by Gonçalves et al.
  ανά: Van Mens, L, κ.ά.
  Έκδοση: (2019)